Acceleron Pharma Inc (XLRN):企業の財務・戦略的SWOT分析

◆英語タイトル:Acceleron Pharma Inc (XLRN) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1319
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Acceleron Pharma Inc (XLRN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Acceleron Pharma Inc (Acceleron) is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutics to treat serious and rare diseases. Reblozyl is the company’s only commercial product used for the treatment of anemia with beta-thalassemia patients who require regular red blood cell (RBC) transfusion. The company’s lead therapeutic candidate, luspatercept-aamt is in Phase III study for the treatment of anemia and associated complications in myelodysplastic syndromes, beta-thalassemia and myelofibrosis. Its other pipeline products are being developed for the treatment of, neuromuscular , pulmonary and associated diseases. The company partners with various biopharmaceutical companies and research institutes to advance the development of its lead products. Acceleron Pharma is headquartered in Cambridge, Massachusetts, the US.

Acceleron Pharma Inc Key Recent Developments

Mar 09,2020: Acceleron Announces Topline Results from the Phase 2 Trial of ACE-083 in Patients with Charcot-Marie-Tooth Disease
Feb 27,2020: Acceleron reports fourth quarter and full year 2019 operating and financial results
Jan 23,2020: Acceleron announces change to executive management team
Dec 31,2019: Acceleron signs pulmonary research and discovery deal with Fulcrum Therapeutics

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Acceleron Pharma Inc – Key Facts
Acceleron Pharma Inc – Key Employees
Acceleron Pharma Inc – Key Employee Biographies
Acceleron Pharma Inc – Major Products and Services
Acceleron Pharma Inc – History
Acceleron Pharma Inc – Company Statement
Acceleron Pharma Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Acceleron Pharma Inc – Business Description
Acceleron Pharma Inc – Corporate Strategy
Acceleron Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
Acceleron Pharma Inc – Strengths
Acceleron Pharma Inc – Weaknesses
Acceleron Pharma Inc – Opportunities
Acceleron Pharma Inc – Threats
Acceleron Pharma Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Acceleron Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Acceleron Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Acceleron Pharma Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jan 23, 2020: Acceleron announces change to executive management team
Dec 31, 2019: Acceleron signs pulmonary research and discovery deal with Fulcrum Therapeutics
Dec 30, 2019: Acceleron and Fulcrum Therapeutics announce pulmonary research and discovery collaboration agreement
Dec 09, 2019: Acceleron appoints Jay T. Backstrom, M.D., M.P.H., to newly created role as head of research and development
Dec 06, 2019: Acceleron appoints Global Innovation and Drug Development Executive Kemal Malik, MB BS, to its Board of Directors
Dec 04, 2019: Acceleron Named a “Most Honored” Company in Institutional Investor 2020 “All-America Executive Team” Rankings
Nov 06, 2019: Acceleron reports third quarter 2019 operating and financial results
Aug 05, 2019: Acceleron reports second quarter 2019 operating and financial results
Jun 10, 2019: Acceleron announces retirement of Director and Co-Founder Tom Maniatis
May 09, 2019: Acceleron reports first quarter 2019 operating and financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Acceleron Pharma Inc, Key Facts
Acceleron Pharma Inc, Key Employees
Acceleron Pharma Inc, Key Employee Biographies
Acceleron Pharma Inc, Major Products and Services
Acceleron Pharma Inc, History
Acceleron Pharma Inc, Subsidiaries
Acceleron Pharma Inc, Key Competitors
Acceleron Pharma Inc, Ratios based on current share price
Acceleron Pharma Inc, Annual Ratios
Acceleron Pharma Inc, Annual Ratios (Cont...1)
Acceleron Pharma Inc, Interim Ratios
Acceleron Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Acceleron Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Acceleron Pharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Acceleron Pharma Inc, Performance Chart (2015 - 2019)
Acceleron Pharma Inc, Ratio Charts
Acceleron Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Acceleron Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Acceleron Pharma Inc (XLRN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HeartWare International Inc:企業の製品パイプライン分析2018
    Summary HeartWare International Inc (HeartWare), subsidiary of Medtronic Plc, is a medical device company that develops and manufactures ventricular assist devices and implantable heart pumps for the treatment of advanced heart failure. The company provides HeartWare Ventricular Assist System that c …
  • Belk Inc:企業の戦略・SWOT・財務情報
    Belk Inc - Strategy, SWOT and Corporate Finance Report Summary Belk Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Essilor International Compagnie Generale d’Optique SA (EI):医療機器:M&Aディール及び事業提携情報
    Summary Essilor International Compagnie Generale d'Optique SA (Essilor) designs, manufactures and distributes ophthalmic lenses, sunwear, reading glasses and optics equipment. The company offers a range of corrective lenses for correcting visual disorders such as myopia, hypermetropia and astigmatis …
  • Faisal Islamic Bank of Egypt (SAE) (FAITA):企業の財務・戦略的SWOT分析
    Faisal Islamic Bank of Egypt (SAE) (FAITA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Immunomic Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Immunomic Therapeutics Inc (ITI) is a clinical-stage biotechnology company that develops patented lysosomal-associated membrane protein or lamp technology based nucleic acid immunotherapy platforms. The company’s vaccines utilize the body’s natural biochemistry to develop immune response inc …
  • Coutts & Co:企業の戦略・SWOT・財務分析
    Coutts & Co - Strategy, SWOT and Corporate Finance Report Summary Coutts & Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Key Petroleum Ltd (KEY):石油・ガス:M&Aディール及び事業提携情報
    Summary Key Petroleum Ltd (Key Petroleum) is an oil and gas exploration and production company that acquires, explores and develops oil and gas properties. The company carries out projects such as Canning Basin and Perth Basin. It holds interest in exploration permits such as EP 438, EP 448, EP 104/ …
  • Halfords Group plc (HFD):企業の戦略的SWOT分析
    Halfords Group plc (HFD) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • GHD Pty Ltd:企業の戦略・SWOT・財務分析
    GHD Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary GHD Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Klabin SA:企業の戦略・SWOT・財務情報
    Klabin SA - Strategy, SWOT and Corporate Finance Report Summary Klabin SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • ComOps Limited (COM):企業の財務・戦略的SWOT分析
    ComOps Limited (COM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Fera Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Fera Pharmaceuticals LLC (Fera) is a pharmaceutical company that develops, markets and commercializes ointments and medicines. The company offers neptazane, bacitracin ophthalmic ointment USP, neo-polycin HC, and others. It offers various treatment options for patient and healthcare communit …
  • Network Rail Limited:企業の戦略・SWOT・財務情報
    Network Rail Limited - Strategy, SWOT and Corporate Finance Report Summary Network Rail Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Avangrid Renewables LLC:電力:M&Aディール及び事業提携情報
    Summary Avangrid Renewables LLC (Avangrid Renewables) a subsidiary of Avangrid Renewables Holdings, Inc., is a renewable energy company that carries out electricity generation from renewable energy sources including wind, biomass, solar energy and thermal energy. The company also provides services s …
  • DiaSys Diagnostic Systems GmbH:医療機器:M&Aディール及び事業提携情報
    Summary DiaSys Diagnostic Systems GmbH (DiaSys Diagnostic) is a developer, manufacturer and marketer of point of care diagnostic products. The company’s products include automated analyzers, calibrators or controls, POCT systems and tests, reagents, system kits and OEM products. It provides automate …
  • STMicroelectronics N.V. (STM)-医療機器分野:企業M&A・提携分析
    Summary STMicroelectronics N.V. (ST) is a microelectronics company that designs, develops, manufactures, and markets a broad range of products for analog, digital, and mixed-signal applications. It offers standard commodity components, custom devices and semi-custom devices, application-specific int …
  • Babcock & Wilcox Enterprises Inc (BW):企業の財務・戦略的SWOT分析
    Babcock & Wilcox Enterprises Inc (BW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Wockhardt Ltd (WOCKPHARMA):製薬・医療:M&Aディール及び事業提携情報
    Summary Wockhardt Ltd (Wockhardt) is a pharmaceutical company that manufactures and markets vaccines, active pharmaceutical ingredients, pharmaceutical and recombinant bio-pharmaceutical formulations. The company's product portfolio caters to various therapeutic areas including orthopedics, dental c …
  • El Paso Electric Company (EE):電力:M&Aディール及び事業提携情報
    Summary El Paso Electric Company (El Paso) is a vertically integrated electric utility, which generates, transmits, and distributes electric power. It produces electricity from nuclear, natural gas, coal, and solar sources. The company has ownership interest in and operates various power generation …
  • Dollar General Corporation:企業のM&A・事業提携・投資動向
    Dollar General Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dollar General Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆